BerGenBio - Director's Dealing 2022

BerGenBio - Mandatory notification of trade by Primary Insider

Bergen, Norway,16 June 2022?-BerGenBioASA (OSE: BGBIO) (the "Company"), has been

notified that Anders Tullgren, Chairman of the Board and primary insider of

BerGenBio ASA, has bought 25,000 shares in BerGenBio ASA at an average price of

NOK 10.73 per share. The shares are purchased under the sign on bonus agreement

approved by the Extraordinary General Meeting 6 January 2022 in connection with

the appointment of Mr. Tullgren as Chairman of the Board in BerGenBio ASA.

After the transaction Mr. Tullgren holds 50,000 shares in BerGenBio ASA.

Please see the attached document for further details of the transaction.

Contact:

Martin Olin, CEO,BerGenBioASA

RuneSkeie, CFO,BerGenBioASA

This information issubject to the disclosure requirements pursuant to the EU

Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities

Trading Act.

AI assistant